Combination of preoperative D-dimer and mean platelet volume predicts postoperative deep venous thrombosis in breast cancer patients

2018 ◽  
Vol 21 (4) ◽  
pp. 909-913 ◽  
Author(s):  
Li-Na Cui ◽  
Na Li ◽  
Shuang Fu ◽  
Xin Zhang ◽  
Xin Wang ◽  
...  
Breast Cancer ◽  
2019 ◽  
Vol 26 (6) ◽  
pp. 712-718 ◽  
Author(s):  
Na Li ◽  
Xin-hai Lv ◽  
Xin Wang ◽  
Rui-tao Wang ◽  
Yuan-xi Huang

2009 ◽  
Vol 52 (3) ◽  
pp. 446-451 ◽  
Author(s):  
Mogens T. Stender ◽  
Jens B. Frøkjær ◽  
Torben B. Larsen ◽  
Søren Lundbye-Christensen ◽  
Ole Thorlacius-Ussing

2012 ◽  
Vol 34 (2) ◽  
pp. 283-287 ◽  
Author(s):  
Arzu Canan ◽  
Sıddıka Sezgin Halıcıoğlu ◽  
Safiye Gürel

Open Medicine ◽  
2018 ◽  
Vol 13 (1) ◽  
pp. 450-455
Author(s):  
Halil Taskaynatan ◽  
Ahmet Alacacioglu ◽  
Yuksel Kucukzeybek ◽  
Umut Varol ◽  
Yasar Yildiz ◽  
...  

AbstractBackgroundMean platelet volume (MPV) is a parameter that increases during thrombotic and cardiovascular events. Tamoxifen (Tmx) and aromatase inhibitors (AIs), which are adjuvant endocrine therapies, may cause serious side effects, such as vascular thrombosis. The present study investigated the changes in MPV values of breast cancer patients receiving long-term adjuvant hormone therapy and the relationship of MPV with adverse effects of hormonotherapy.MethodsData of 261 patients who had pathologically confirmed estrogen or progesterone receptor positive invasive breast cancer and had received hormonotherapy for at least a 5-year period were retrospectively analyzed. MPV levels were measured at baseline and at the first and fifth year of hormone therapy.ResultsAll patients were females and their median age was 50 years (range, 27–78 years). The mean MPV value was significantly increased in all patients in the Tmx, AI, and switch groups over time (p<0.001).ConclusionThis is the first study evaluating the relationship between the 5-year adjuvant endocrine therapy and changes in MPV values in breast cancer patients. Monitoring changes in MPV values may be predictive for severe side effects in breast cancer patients receiving hormone therapy.


2003 ◽  
Vol 337 (1-2) ◽  
pp. 177-179 ◽  
Author(s):  
Sema Genç ◽  
Funda Tanrıkulu-Kılıç ◽  
Figen Gürdöl ◽  
Yeşim Ünlüçerçi ◽  
Pınar Üler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document